Zentek Ltd. (NASDAQ: ZTEK)

Zentek Ltd. is a research and development company that focuses on graphene nanomaterials and their application in advanced materials clean technology and green energy solutions. The company leverages its intellectual property laboratory capabilities and university partnerships to develop products such as antimicrobial coatings and functionalized graphene additives.

Zentek Ltd. generates revenue primarily through the sale of its ZenGUARD antimicrobial coating to partners who incorporate it into personal protective equipment and HVAC filters. Additional revenue comes from licensing agreements for its patented technologies and from the sale of coated materials to distributors such as EkoMed VMedCare and Southmedic.

Zentek Ltd. occupies a niche within the broader graphene industry where it differentiates itself through a portfolio of patented antimicrobial technologies and a potential vertical integration route via its wholly owned Albany Graphite Project. The company competes with other graphene producers and advanced material firms but believes its scientific know how intellectual property and pilot scale production capabilities give it a competitive edge.

Zentek Ltd. sells its coated products to personal protective equipment manufacturers HVAC system suppliers and distributors including EkoMed VMedCare and Southmedic. The company also works with other parties interested in representing or distributing its products in markets such as Europe India Australia and Asia.